ENT Department, Carol Davila University of Medicine and Pharmacy, 050472 Bucharest, Romania.
Department of Cardiovascular Surgery, "Prof. Dr. Agrippa Ionescu" Emergency Clinical Hospital, 011356 Bucharest, Romania.
Medicina (Kaunas). 2023 Jun 17;59(6):1167. doi: 10.3390/medicina59061167.
Schwannomas (neurilemomas) are benign, slow-growing, encapsulated, white, yellow, or pink tumors originating in Schwann cells in the sheaths of cranial nerves or myelinated peripheral nerves. Facial nerve schwannomas (FNS) can form anywhere along the course of the nerve, from the pontocerebellar angle to the terminal branches of the facial nerve. In this article, we propose a review of the specialized literature regarding the diagnostic and therapeutic management of schwannomas of the extracranial segment of the facial nerve, also presenting our experience in this type of rare neurogenic tumor. The clinical exam reveals pretragial swelling or retromandibular swelling, the extrinsic compression of the lateral oropharyngeal wall like a parapharyngeal tumor. The function of the facial nerve is generally preserved due to the eccentric growth of the tumor pushing on the nerve fibers, and the incidence of peripheral facial paralysis in FNSs is described in 20-27% of cases. Magnetic Resonance Imaging (MRI) examination is the gold standard and describes a mass with iso signal to muscle on T1 and hyper signal to muscle on T2 and a characteristic "darts sign." The most practical differential diagnoses are pleomorphic adenoma of the parotid gland and glossopharyngeal schwannoma. The surgical approach to FNSs requires an experienced surgeon, and radical ablation by extracapsular dissection with preservation of the facial nerve is the gold standard for the cure. The patient's informed consent is important regarding the diagnosis of schwannoma and the possibility of facial nerve resection with reconstruction. Frozen section intraoperative examination is necessary to rule out malignancy or when sectioning of the facial nerve fibers is necessary. Alternative therapeutic strategies are imaging monitoring or stereotactic radiosurgery. The main factors which are considered during the management are the extension of the tumor, the presence or not of facial palsy, the experience of the surgeon, and the patient's options.
神经鞘瘤(神经鞘瘤)是起源于颅神经或有髓周围神经鞘的施万细胞的良性、生长缓慢、包膜的白色、黄色或粉红色肿瘤。面神经神经鞘瘤(FNS)可在神经的任何部位形成,从桥小脑角到面神经的终末分支。在本文中,我们提出了对面神经颅外段神经鞘瘤的诊断和治疗管理的专业文献综述,同时介绍了我们在这种罕见神经源性肿瘤类型中的经验。临床检查显示咽旁肿胀或下颌后肿胀,外侧咽旁壁受压类似于咽旁肿瘤。由于肿瘤偏心生长压迫神经纤维,面神经的功能通常得以保留,面神经 FNS 中周围性面瘫的发生率为 20-27%。磁共振成像(MRI)检查是金标准,描述了一个在 T1 上与肌肉等信号、在 T2 上高信号的肿块,以及一个特征性的“飞镖征”。最实用的鉴别诊断是腮腺多形性腺瘤和舌咽神经鞘瘤。FNS 的手术方法需要有经验的外科医生,通过包膜外解剖进行根治性消融,同时保留面神经是治愈的金标准。患者的知情同意对于神经鞘瘤的诊断和面神经切除与重建的可能性很重要。术中需要进行冰冻切片检查以排除恶性肿瘤,或在需要面神经纤维切开时。替代治疗策略是影像学监测或立体定向放射外科。管理中考虑的主要因素是肿瘤的范围、是否存在面瘫、外科医生的经验以及患者的选择。